Insulin resistance may be related to recurrent miscarriages, a condition affecting approximately 2-5% of women of reproductive age Another study evaluates the presence of a family of proteins that protect…
In the ever-evolving landscape of global healthcare, IVIRMA Global stands as an inspiration for progress, dedicated to providing the best possible care and achieving optimal outcomes for patients undergoing infertility…
IVIRMA Research Presented at ASRM 2023 Shapes the Future of Reproductive Medicine BASKING RIDGE, NJ, October 19, 2023 – IVIRMA Global, the largest reproductive medicine group in the world, has…
IVIRMA ) Global Research Alliance is one of the four pillars of IVIRMA Global, the world’s largest company exclusively devoted to human Assisted Reproduction Technology (ART). A reality that began to take shape in 2017, IVIRMA ) Global Research Alliance strives to lead scientific research and technology development in reproductive medicine and ART, with the ultimate aim of improving patient care.
To redefine the present and shape the future, IVIRMA brings together innovative investigators from the Old and the New Continent, promotes refining research techniques and encourages sharing knowledge.
Scientific innovation, technological progress, educational commitment, and clinical expertise… with one common goal: Excellence in Patient Care.
